Chemotherapy and immunosupression of kidney transplant recipients.
Little progress has been made in immunosuppressive therapy for kidney transplant patients in the last decade. A more rational approach to investigation, both experimentally and clinically, is needed so that available immunosuppressive agents can be used with maximum effectiveness and minimal side effects. Well-designed, randomized, prospective multicentre trials must be performed in the future if we are to obtain definitive answers.
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone